Anthony Strickland
Family Medicine · Lawrence, KSNPI 1790048239
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2022 is the largest year on record at $835, 4.1 times the $204 reported in 2019.
Across 124 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$365
- GSK$181
- Lilly USA, LLC$146
- Amgen$125
- Pfizer$116
- Teva Pharmaceuticals USA, Inc.$103
- plus $933 from 24 others
What the payments were for
- Food & beverage$1,95799%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $365 |
| GSK | 6 | $181 |
| Lilly USA, LLC | 10 | $146 |
| Amgen | 7 | $125 |
| Pfizer | 9 | $116 |
| Teva Pharmaceuticals USA, Inc. | 7 | $103 |
| Boehringer Ingelheim | 6 | $83 |
| Novo Nordisk | 4 | $73 |
| Bayer | 4 | $67 |
| Antares Pharma, Inc. | 4 | $66 |
| Mylan Specialty L.p. | 4 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Eisai Inc. | 3 | $52 |
| AstraZeneca(2 entities) | 4 | $52 |
| Merck | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Johnson & Johnson | 3 | $44 |
| Abbott | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Biomerieux Inc | 1 | $17 |
| Biofire Diagnostics, LLC | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Novartis | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$121
How this compares
$1,968 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $2,420 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $901 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $345 |
| Testosterone Cypionate | 11 | $101 |
| Gabapentin | 15 | $68 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lawrence
- David StricklandLawrence$53K
- Larisa KimuriLawrence$23K
- Stephanie SuberLawrence$10K
- Bradley HarrisonManhattan$314K
- Mila MeansWichita$241K
- Scott AveryJunction City$195K
- Kent KiracofeManhattan$189K
- Terry McGeeneyLeawood$147K
- Cole GillenwaterWichita$62K
- Kyle PlatzManhattan$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.